CHA ÀÇ°úÇдëÇб³ Â÷º´¿ø professor

±³¼ö´Ô»çÁø
  • ±èÀº°æ
  • ¼Ò ¼Ó: ºÐ´çÂ÷º´¿ø
  • Àü¹®ºÐ¾ß : ¸¸¼ºÆó¼â¼ºÆóÁúȯ, Æó°áÇÙ, °£Áú¼ºÆóÁúȯ, Æó¾Ï
  • Á÷ À§: ºÎ±³¼ö
  • ¸Þ ÀÏ:
  • Àü È­: 1577-4488
  • ÆÑ ½º:
  • ÁÖ ¼Ò: °æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßž·Î 59
  • ȨÆäÀÌÁö:
  • ·Î±×ÀÎ

ÅǸ޴º

ÁÖ¿ä¹ßÇ¥³í¹®

ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£ ±¸ºÐ Á¦¸ñ
18 (±¹³»)SCOPUS °áÇÙ¼º Æı«Æó¿¡ ÀÇÇÑ Æóµ¿¸Æ °íÇ÷¾Ð ȯÀÚ¿¡¼­ ¹ß°ßµÈ ±ÙÀ§ºÎ Æóµ¿¸Æ Ç÷ÀüÁõ 1¿¹
17 (±¹¿Ü)SCI Quantitative Assessment of Emphysema, Air Trapping, and Airway Thickening on Computed Tomography
16 (±¹³»)KCI Myasthenia Gravis Presenting as Isolated Respiratory Failure
15 (±¹³»)SCOPUS Æó¾ÏÀÇ Áø´Ü°Ë»ç Áß ±â°üÁö¼¼Ã´¾×¿¡¼­ ThinPrep°Ë»ç¹ý°ú ±âÁ¸ÀÇ ¼¼Æ÷°Ë»ç¹ýÀÇ À¯¿ë¼º¿¡ ´ëÇÑ ºñ±³
14 (±¹³»)SCOPUS Èä¼öÀÇ °¨º° Áø´Ü ½Ã Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM)ÀÇ À¯¿ë¼º
13 (±¹³»)KCI ¸¸¼º °£Áúȯ ȯÀÚ¿¡¼­ °£Áúȯ ƯÀÌÀû »îÀÇ Áú µµ±¸¿¡ °üÇÑ Çѱ¹¾î ¹ø¿ª ¼³¹®ÁöÀÇ Å¸´ç¼º¿¡ ´ëÇÑ Á¶»ç
12 (±¹³»)KCI Ç×¾ÏÄ¡·á ȯÀÚÀÇ BÇü ¹× CÇü °£¿°¹ÙÀÌ·¯½º °¨¿°°ú °£±â´É ÀÌ»ó
11 (±¹³»)KCI °æÇǹè¾×¼ú·Î Ä¡·áÇÑ ½ÊÀÌÁöÀå º®³» Ç÷Á¾ 1¿¹
10 (±¹³»)KCI À¯ÀüÀÚÇü °Ë»ç¸¦ ÅëÇØ Áø´ÜµÈ ÀڱðæºÎ¾ÏÀÇ ±â°üÁö³» ÀüÀÌ 1¿¹
9 (±¹³»)KCI Helicobacter pylori Á¦±ÕÄ¡·á¿¡¼­ Levofloxacin º´ÇÕ¿ä¹ýÀÇ È¿°ú
ÀÌÀüÆäÀÌÁö À̵¿ 11 12 13 14 15 16 17 ´ÙÀ½ÆäÀÌÁö À̵¿
Copyright ¨Ï chamc, All rights reserved.

ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à

  • °­³²Â÷º´¿ø
  • ºÐ´çÂ÷º´¿ø
  • ºÐ´çÂ÷¿©¼ºº´¿ø
  • ±¸¹ÌÂ÷º´¿ø
  • ¿©¼ºÀÇÇבּ¸¼Ò
  • Â÷¿ò

ÀüÈ­¹®ÀÇ

  • °­³²Â÷º´¿ø 02.3468.3000
  • ºÐ´çÂ÷º´¿ø 031.780.5000
  • Â÷¿ò 02.3015.5300
  • ±¸¹ÌÂ÷º´¿ø 054.450.9700
  • ´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
  • °­³²°ÇÁø¼¾ÅÍ 02.2191.3900
  • ºÐ´çÁ¾ÇÕ°Ç°­ÁõÁø¼¾ÅÍ 031.780.5940
  • ½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
  • ±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
  • ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729